Skip to content
GLP-1 Decoder

GLP-1 and Two Drugs at Once: Is It Safe? Label and Studies

Do not take two GLP-1 medicines together; the labels say combining them is not recommended.

Verdict
Avoid together
Label interaction lines
2

Weight loss and half-life at a glance

How long each stays in your body
Wegovy7 dOzempic7 dRybelsus7 dZepbound5.5 dMounjaro5 dTrulicity5 dFoundayo1.6 dSaxenda0.5 dVictoza0.5 dByetta0.1 d

In days, half-life means how long your body needs to remove half a dose. Each FDA label gives this figure in section 12.3.

Weight loss reported in the main weight trial of each medicine
Zepbound20.9%Wegovy14.9%Foundayo11.1%Saxenda7.4%

Share of body weight. Trials, doses and lengths differ, so compare each one with the placebo on its own page.

Sources (10)

FDA label from DailyMed 1 2 3 4 5 6 7 8 9 10.

GLP-1 medicines alongside a second GLP-1 medicine: the verdict

Avoid together

The labels for Wegovy and Zepbound say not to take either medicine alongside another GLP-1 medicine or a different product with the same ingredient.

What the label says about interactions

Every interaction that the Ozempic label lists. Any question about a second GLP-1 medicine falls under one of these.

Drug interactions included in the Ozempic label
Named in the labelThe riskWhat the label tells doctors
Insulin or sulfonylureasLow blood sugarUsing it with insulin or a sulfonylurea, such as glipizide or glimepiride, makes low blood sugar more likely; your doctor may lower those doses.
Oral medicinesPills absorbed differentlyIt slows the emptying of your stomach, and that can change how other pills are absorbed.

Source: Ozempic label (DailyMed).

What the studies show

Label source: DailyMed FDA label.

The practical rule

If you are switching medicines, stop the first one the way your prescriber's plan directs, before you start the other.

Label source: DailyMed FDA label.

Other GLP-1s taken with a second GLP-1 medicine

None of the 10 GLP-1 labels has a drug interaction section that names A second GLP-1 medicine.